Sight Sciences (SGHT) Prices 10M Share IPO at $24/sh

Sight Sciences, Inc., a growth-stage medical device company focused on the development and commercialization of proprietary devises that target the underlying causes of the world’s most prevalent eye diseases, today announced the pricing of its initial public offering of 10,000,000 shares of common stock at a public offering price of $24.00 per share. All shares of common stock are being offered by Sight Sciences for total gross proceeds of $240 million, before deducting underwriting discounts and commissions and offering expenses. In addition, Sight Sciences has granted the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions. Sight Sciences’s common stock is expected to begin trading on the Nasdaq Global Market on July 15, 2021, under the ticker symbol “SGHT.” The offering is expected to close on July 19, 2021, subject to the satisfaction of customary closing conditions.

Morgan Stanley and BofA Securities are acting as joint lead book-running managers for the offering. Citigroup and Piper Sandler are also acting as book-running managers for the offering.

Registration statements relating to the shares being sold in this offering have been filed with the Securities and Exchange Commission and declared effective. The offering is being made only by means of a prospectus. When available, a copy of the final prospectus may be obtained from: Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014, via telephone at +1 (866) 718-1649 or by email at [email protected] or from BofA Securities, Attention: Prospectus Department, NC1-004-03-43, 200 North College Street, 3rd floor, Charlotte, NC 28255-0001, by telephone at 1-800-294-1322 or by email at [email protected].

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

You May Also Be Interested In

• SpaceX sets IPO price at $135 ahead of roadshow in break with Wall Street norms
• AEVEX prices public offering of 8 million shares at $27 each
• ATI prices $450 million senior notes offering due 2033